SOLVE-RD: Major European grant for research into rare diseases Blog Post

The CNAG-CRG at PCB participates in a large consortium led by the University of Tübingen, the Radboud University Medical Center Nijmegen and the University of Leicester that has acquired a € 15 million grant for the SOLVE-RD research program he researchers will work directly with four European Reference Networks (ERNs) to share and enhance the knowledge and resources used for treating rare diseases.

 

Chemotargets signs a research collaboration agreement with FDA/CDER Blog Post

The Food and Drug Administration’s Center for Drug Evaluation and Research (FDA-CDER) and Chemotargets –a spin off from the IMIM Hospital del Mar Medical Research Institut and located at the Barcelona Science Park– will work together under a 5-year Research Collaboration Agreement (RCA). The collaboration aims to enhance CDER’s safety assessments of human pharmaceuticals, supporting the FDA’s mission of protecting public health.

 

Esteve picks up Company of the Year Award Blog Post

Esteve has won the Company of the Year Award 2017 which is sponsored by Grupo Zeta and Banc Sabadell and recognises contributions to creating wellbeing and progress. The pharmaceutical chemical group, which has its Drug Discovery and Preclinical Development Units at the Barcelona Science Park, is a leader in the international pharmaceutical industry due to its continuous innovation in the traditional R&D model and unswerving commitment to promoting excellence in research ecosystems. Albert Esteve, the company’s Chairman, is to collect the award today at Casa Llotja de Mar in Barcelona at a ceremony attended by a wide range of political, social and industry figures.

 

Bioinformatics company Mind the Byte acquires Intelligent Pharma Blog Post

Mind the Byte a pioneer in the development of technologies based on artificial intelligence, cloud and big data for computational drug design, has acquired 100% of Intelligent Pharma, one of the leaders in Spain in chemoinformatics services for the pharmaceutical and biotechnology industry. Both bioinformatics companyies are headquartered in the Barcelona Science Park (Parc Científic de Barcelona, PCB) which will help the integration process under which Mind the Byte expects to reach €2 million in turnover by 2019.

 

Presenting CataloniaBio & HealthTech Blog Post

A new era for the CataloniaBio association of companies and the HealthTech Cluster. Members of the two organisations unanimously passed the motion to merge under the brand CataloniaBio & HealthTech at their respective extraordinary general meetings held in Barcelona yesterday.The headquarters will be located at the Barcelona Science Park. It will promote the convergence of biopharma, MedTech and digital health companies to boost competitiveness and address unmet medical needs 

 

Cebiotex launches a €650,000 crowdfunding campaign to ensure that its oncological treatment reaches paediatrics Blog Post

Cebiotex—with headquarters in the Barcelona Science Park (PCB)—has launched an equity crowdfunding campaign of €650,000 through Capital Cell to ensure that its first drug, CEB-01, used in the local post-surgical treatment of soft tissue sarcomas, also reaches paediatric oncology. CEB-01 is the first therapeutic application of its innovative technology, which are based on nanofibres, for local drug delivery. In the future, however, the company aims to develop new applications for pancreatic and liver cancer, as well as glioblastoma.Since it was formed in 2012, Cebiotex has raised over €2 million from public and private funds. The success of the previous equity crowdfunding campaigns and the participation of impactful social investors has allowed Cebiotex to maintain a paediatric focus as one of the company’s strategic objectives.

 

The PCB receives the secondary award for best practice in science and technology parks of APTE Blog Post

Ignasi Belda, CEO of the Barcelona Science Park (PCB), has received this morning the secondary prize of the ‘Award for best practice in science and technology parks of Apte’ in the category of parks with an age of more than 10 years. The award ceremony has been delivered within the framework of the XV International Conference of the Association of Science and Technology Parks of Spain (APTE), which is being held today at the Gipuzkoa Science and Technology Park under the name “Beyond 2020: disruptive technologies“.

 

Genesis Biomed presents its new Genesis Ventures fund Blog Post

Today Genesis Biomed has presented at the Barcelona Science Park a new investment fund, Genesis Ventures, made up of various family offices that are looking to invest in research and business projects in the very early stages in the field of biomedicine. With this initiative, the company based at PCB, wants to help entrepreneurs put together the capital they need for their research in order to later attract series-A corporate funds or venture capital.

 

Entities from PCB promote their international presence at BIO-Europe 2017 Blog Post

From 6 to 8 November, Belin will host BIO-Europe 2017, the largest partnering gathering of the biotech and pharmaceutical industry in Europe and one of the largest in the world. The event, organized by EBD-Group with the collaboration of Biocat –based at the Barcelona Science Park (PCB)– will again draw over 3,800 industry attendees from over 60 countries, representing more than 2,000 companies and It will have a important representation of PCB.